Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding Population Health Management Practices Among Family Medicine Residency Programs.

Family medicine·2025
Same author

How Different Are Family Medicine Residents Who Desire Additional Training?

Family medicine·2025
Same author

Advanced Practice Providers in Departments of Family Medicine: Status, Supervision, and Services.

Journal of the American Board of Family Medicine : JABFM·2024
Same author

Variation in Practice Patterns of Early- and Later-Career Family Physicians.

Journal of the American Board of Family Medicine : JABFM·2023
Same author

The Association Between Family Medicine Appointment Cancellations and Hospital Utilization in 2019 and 2020.

Journal of the American Board of Family Medicine : JABFM·2023
Same author

Are We Preparing Residents for Their Actual Practices?

Journal of graduate medical education·2022

Related Experiment Video

Updated: Jul 13, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Prevention of recurrent ischemic stroke.

Lori M Dickerson1, Peter J Carek, Robert Glen Quattlebaum

  • 1Trident Medical Center/Medical University of South Carolina Family Medicine Residency Program, Charleston, South Carolina 29406, USA. macfarll@musc.edu

American Family Physician
|August 22, 2007
PubMed
Summary

Preventing recurrent ischemic stroke involves managing risk factors and lifestyle. Aspirin with dipyridamole is often superior to aspirin alone, while clopidogrel suits aspirin-intolerant patients.

Related Experiment Videos

Last Updated: Jul 13, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Primary Care Medicine

Background:

  • Recurrent ischemic stroke and transient ischemic attack (TIA) are significant health concerns, necessitating frequent primary care management.
  • Stroke survivors typically require around 10 outpatient visits annually, highlighting the need for effective long-term care strategies.
  • Key risk factors including hypertension, diabetes, and hypercholesterolemia demand continuous evaluation and management during patient visits.

Purpose of the Study:

  • To outline current best practices for the prevention of recurrent ischemic stroke and transient ischemic attack (TIA).
  • To review the efficacy and indications for various antiplatelet and anticoagulant agents.
  • To discuss the role of lifestyle modifications and surgical interventions in stroke prevention.

Main Methods:

  • Evaluation of risk factors such as hypertension, diabetes, and hypercholesterolemia.
  • Emphasis on lifestyle modifications: obesity management, smoking cessation, reduced alcohol consumption, and physical activity promotion.
  • Review of antiplatelet agents (aspirin, ticlopidine, clopidogrel, dipyridamole) and anticoagulants (warfarin) based on safety, tolerability, effectiveness, and cost.

Main Results:

  • Aspirin is a common initial choice, but the combination of dipyridamole and aspirin demonstrated superior effectiveness in clinical trials.
  • Clopidogrel is recommended for patients with aspirin or dipyridamole intolerance.
  • Warfarin and the combination of aspirin plus clopidogrel are not recommended for ischemic stroke prevention.
  • Carotid endarterectomy is suitable for select patients; carotid stenting showed inferior efficacy and safety compared to endarterectomy.

Conclusions:

  • Comprehensive management of risk factors and lifestyle modifications are crucial for preventing recurrent ischemic stroke.
  • Combination therapy with aspirin and dipyridamole offers superior protection for many patients.
  • Clopidogrel serves as an alternative for specific patient populations.
  • Carotid endarterectomy remains a preferred surgical option over carotid stenting for appropriate candidates.